Skip to content

EQUUS TOTAL RETURN, INC.: 10-K/A filed 2025-12-18

What EQUUS TOTAL RETURN, INC. reported in its annual report amendment filed 2025-12-18 (fiscal FY 2023): 24 published measures, 67 facts as tagged in accession 0001096906-25-002127.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-K/A (annual report amendment)
Filed
2025-12-18
Fiscal period
fiscal FY 2023
Accession
0001096906-25-002127 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All EQUUS TOTAL RETURN, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-12-3193,547,000USD
At 2022-12-3141,664,000USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-12-3145,260,000USD
At 2022-12-316,427,000USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-12-3148,287,000USD
At 2022-12-3135,237,000USD
At 2021-12-3136,365,000USD
At 2020-12-3133,777,000USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-12-316,533,000USD
At 2022-12-3119,224,000USD
At 2021-12-3123,465,000USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-01-01 to 2023-12-3112,949,000USD365
2022-01-01 to 2022-12-31-1,128,000USD365
2021-01-01 to 2021-12-312,588,000USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-12-31-51,359,000USD365
2022-01-01 to 2022-12-31-7,704,000USD365
2021-01-01 to 2021-12-3121,111,000USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-12-3139,058,000USD365
2022-01-01 to 2022-12-313,498,000USD365
2021-01-01 to 2021-12-31-21,500,000USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-12-31-26,512,000USD
At 2022-12-31-39,461,000USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-01-01 to 2023-12-3113,526,000shares365
2022-01-01 to 2022-12-3113,518,000shares365
2021-01-01 to 2021-12-3113,518,000shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-01-01 to 2023-12-310.96USD/shares365
2022-01-01 to 2022-12-31-0.08USD/shares365
2021-01-01 to 2021-12-310.19USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2023-01-01 to 2023-12-3113,000USD365
2022-01-01 to 2022-12-3115,000USD365
2021-01-01 to 2021-12-3125,000USD365

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-01-01 to 2023-12-310USD365
2021-01-01 to 2021-12-310USD365

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-01-01 to 2023-12-3125,000USD365
2022-01-01 to 2022-12-314,000USD365
2021-01-01 to 2021-12-313,000USD365

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-12-31172,000USD
At 2022-12-31107,000USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-01-01 to 2023-12-314,284,000USD365
2022-01-01 to 2022-12-313,629,000USD365
2021-01-01 to 2021-12-313,453,000USD365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2023-01-01 to 2023-12-31133,000USD365
2022-01-01 to 2022-12-31130,000USD365
2021-01-01 to 2021-12-31140,000USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-12-3113,586,173shares
At 2022-12-3113,518,146shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-12-316,983,000USD
At 2022-12-3119,284,000USD
At 2021-12-3123,490,000USD
At 2020-12-3123,879,000USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-12-3174,785,000USD
At 2022-12-3174,685,000USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-01-01 to 2023-12-3112,949,000USD365
2022-01-01 to 2022-12-31-1,128,000USD365
2021-01-01 to 2021-12-312,588,000USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-01-01 to 2023-12-3125,000USD365
2022-01-01 to 2022-12-314,000USD365
2021-01-01 to 2021-12-314,000USD365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2023-01-01 to 2023-12-3113,000USD365
2022-01-01 to 2022-12-3153,000USD365
2021-01-01 to 2021-12-3125,000USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-01-01 to 2023-12-31101,000USD365
2022-01-01 to 2022-12-310USD365
2021-01-01 to 2021-12-310USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-12-310USD365
2022-01-01 to 2022-12-310USD365
2021-01-01 to 2021-12-31-3,413,000USD365

Inspect the source

Entity
EQUUS TOTAL RETURN, INC. / CIK 0000878932
Captured
2026-09-20T05:01:23.680Z
SEC response SHA-256
a2d55934bc12c170293e3935fdcee8249cfccd7eb3e3ddc170de1c0a6b15cc25

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000878932.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))